Colds and flu Archive

Urinary tract infections (UTIs) occur in women of all ages. Physical and hormonal changes can leave women at midlife particularly vulnerable. No woman should have to put up with the inconvenience and discomfort of recurrent UTIs. Self-help measures can be effective, but if they don’t do the trick, see your doctor. He or she can identify and treat any underlying problems and recommend other strategies to keep UTIs at bay.

Ask the doctor

Q. I heard there is a high-dose flu vaccine that could work better in older people. Is it safe even if a man has a medical problem like cancer or heart disease?

A. The high-dose flu vaccine is very similar to the standard flu vaccine but appears to provide slightly better protection against influenza. Both vaccines target three different strains of the flu virus, selected from the most common strains predicted to be circulating that year. The viruses are inactivated, or killed, so they cannot cause the flu, even in people with weakened immune systems. Finally, both vaccines can cause mild symptoms of arm pain, redness, muscle aches, or low-grade fever. Although most people have minimal to no symptoms, the high-dose vaccine may slightly increase the side effects.

If you got the flu shot last year and it didn't work, don't reject vaccination.

During last year's battle of The People vs. Influenza, the virus gained the upper hand. Early in the 2014–15 flu season, a new strain of the virus emerged against which the existing vaccine offered virtually no protection. Hospitalizations for flu in older adults spiked to the highest level in a decade.

Some years the flu vaccine works quite well. Other years it doesn’t. It has done a particularly poor job this year against the main flu virus. The CDC reported yesterday that this year’s flu vaccine has been just 18% effective. The estimate for children is even lower. And it looks like the nasal spray vaccine may not have worked at all among children. One reason for this year’s mismatch between virus and vaccine is that experts must decide months in advance which of the hundreds of flu viruses to include in the vaccine. What became the dominant flu virus this year, a new strain of H3N2 influenza A, wasn’t around last year when experts were determining this year’s vaccine.